TY  - GEN
AU  - Lawitz,Eric
AU  - Matusow,Gary
AU  - DeJesus,Edwin
AU  - Yoshida,Eric M
AU  - Felizarta,Franco
AU  - Ghalib,Reem
AU  - Godofsky,Eliot
AU  - Herring,Robert W
AU  - Poleynard,Gary
AU  - Sheikh,Aasim
AU  - Tobias,Hillel
AU  - Kugelmas,Marcelo
AU  - Kalmeijer,Ronald
AU  - Peeters,Monika
AU  - Lenz,Oliver
AU  - Fevery,Bart
AU  - De La Rosa,Guy
AU  - Scott,Jane
AU  - Sinha,Rekha
AU  - Witek,James
TI  - Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)
SN  - 1527-3350
PY  - 2017///0717
KW  - Adult
KW  - Aged
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Drug Therapy, Combination
KW  - Female
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Simeprevir
KW  - Sofosbuvir
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hep.28422
ER  -